Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$74.85 /

+1.82 (+2.49%)

, PRAX

Praxis Precision Medicines

$32.86 /

+3.25 (+10.98%)

04:55
04/01/21
04/01
04:55
04/01/21
04:55

Stifel to hold a virtual conference

Stifel Virtual CNS Day 2021 will be held on March 31-April 1.

SAGE

Sage Therapeutics

$74.85 /

+1.82 (+2.49%)

PRAX

Praxis Precision Medicines

$32.86 /

+3.25 (+10.98%)

CERE

Cerevel Therapeutics

$13.73 /

+1.36 (+10.99%)

KRTX

Karuna Therapeutics

$119.93 /

+2.66 (+2.27%)

PASG

Passage Bio

$17.55 /

+0.8 (+4.78%)

TSHA

Taysha Gene Therapies

$20.21 /

-0.33 (-1.61%)

BIIB

Biogen

$280.05 /

+4.17 (+1.51%)

XENE

Xenon Pharmaceuticals

$17.94 /

+0.59 (+3.40%)

STOK

Stoke Therapeutics

$38.92 /

+1.89 (+5.10%)

ZGNX

Zogenix

$19.52 /

+0.33 (+1.72%)

AVDL

Avadel Pharmaceuticals

$9.11 /

+0.28 (+3.17%)

QURE

uniQure

$33.75 /

+0.53 (+1.60%)

  • 05

    Apr

  • 15

    Apr

  • 24

    May

  • 07

    Jun

  • 15

    Oct

  • 29

    Apr

  • 24

    Sep

  • 16

    Oct

  • 20

    Nov

  • 22

    Jan

  • 02

    Mar

  • 10

    Mar

SAGE Sage Therapeutics
$74.85 /

+1.82 (+2.49%)

02/26/21 Mizuho
Sage Therapeutics downgraded to Neutral from Buy at Mizuho
02/25/21 Oppenheimer
Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
02/25/21 H.C. Wainwright
Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
02/24/21 Stifel
Stifel cuts Sage target to $121, reiterates Buy after quarterly results
PRAX Praxis Precision Medicines
$32.86 /

+3.25 (+10.98%)

03/17/21 Piper Sandler
Piper sees 114 IND, pivotal trial as sign of Praxis regulatory capabilities
01/21/21 Wedbush
Praxis Precision Medicines price target raised to $61 from $51 at Wedbush
11/17/20 Piper Sandler
Praxis Precision clinical hold looks like 'formality,' says Piper Sandler
11/11/20
Fly Intel: Top five analyst initiations
CERE Cerevel Therapeutics
$13.73 /

+1.36 (+10.99%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
KRTX Karuna Therapeutics
$119.93 /

+2.66 (+2.27%)

03/22/21 BofA
Karuna Therapeutics initiated with a Buy at BofA
03/01/21 Oppenheimer
Karuna Therapeutics price target raised to $148 from $135 at Oppenheimer
02/26/21 Mizuho
Karuna Therapeutics price target raised to $150 from $116 at Mizuho
02/26/21 JMP Securities
Karuna Therapeutics price target raised to $167 from $122 at JMP Securities
PASG Passage Bio
$17.55 /

+0.8 (+4.78%)

03/08/21 Chardan
Passage Bio price target raised to $45 from $35 at Chardan
03/04/21 Citi
Citi remains buyer of Passage Bio into first clinical data
03/04/21 Goldman Sachs
Passage Bio upgraded to Buy from Neutral at Goldman Sachs
02/04/21
Fly Intel: Top five analyst initiations
TSHA Taysha Gene Therapies
$20.21 /

-0.33 (-1.61%)

03/04/21 Chardan
Taysha Gene Therapies price target raised to $60 from $45 at Chardan
02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
BIIB Biogen
$280.05 /

+4.17 (+1.51%)

03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/25/21 Mizuho
Two 'low probability' Biogen events could drive upside, says Mizuho
03/23/21 Piper Sandler
Neurologist survey shows erosion for Biogen franchises, says Piper Sandler
02/17/21 Cantor Fitzgerald
Biogen price target lowered to $268 from $278 at Cantor Fitzgerald
XENE Xenon Pharmaceuticals
$17.94 /

+0.59 (+3.40%)

10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
10/02/20 SVB Leerink
Xenon Pharmaceuticals initiated with an Outperform at SVB Leerink
07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Needham
Xenon Pharmaceuticals initiated with a Buy at Needham
STOK Stoke Therapeutics
$38.92 /

+1.89 (+5.10%)

03/29/21 Canaccord
Stoke Therapeutics weakness a buying opportunity, says Canaccord
03/11/21 Canaccord
Stoke Therapeutics price target raised to $76 from $72 at Canaccord
03/10/21 Credit Suisse
Stoke Therapeutics price target raised to $58 from $49 at Credit Suisse
02/10/21 Wedbush
Stoke Therapeutics downgraded to Neutral at Wedbush
ZGNX Zogenix
$19.52 /

+0.33 (+1.72%)

02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
AVDL Avadel Pharmaceuticals
$9.11 /

+0.28 (+3.17%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
QURE uniQure
$33.75 /

+0.53 (+1.60%)

03/29/21 H.C. Wainwright
uniQure probe 'important first step' toward lifting hold, says H.C. Wainwright
03/02/21 Chardan
uniQure price target raised to $100 from $85 at Chardan
12/22/20 Chardan
uniQure selloff on clinical hold brings good entry point, says Chardan
12/22/20 Jefferies
uniQure's EtranaDez unlikely to raise HCC risk in hemB patients, says Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Pinterest, Snap shares sold by ARK Fintech Innovation ETF » 10:44
06/22/21
06/22
10:44
06/22/21
10:44
PINS

Pinterest

$73.33 /

+2.18 (+3.06%)

, SNAP

Snap

$62.94 /

-0.66 (-1.04%)

, ARKF

ARK Fintech Innovation ETF

$51.75 /

+0.02 (+0.04%)

, ARKQ

ARK Autonomous Technology & Robotics ETF

$82.24 /

+0.37 (+0.45%)

, BABA

Alibaba

$210.09 /

-0.95 (-0.45%)

, BLDE

Blade Air Mobility

$10.65 /

-0.6 (-5.33%)

ARK Investment Management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$73.33 /

+2.18 (+3.06%)

SNAP Snap
$62.94 /

-0.66 (-1.04%)

ARKQ ARK Autonomous Technology & Robotics ETF
$82.24 /

+0.37 (+0.45%)

BABA Alibaba
$210.09 /

-0.95 (-0.45%)

BLDE Blade Air Mobility
$10.65 /

-0.6 (-5.33%)

PINS Pinterest
$73.33 /

+2.18 (+3.06%)

05/10/21 Arete
Pinterest initiated with a Buy at Arete
05/10/21 Citi
Pinterest price target lowered to $65 from $85 at Citi
04/30/21 MKM Partners
Twitter price target lowered to $83 from $95 at MKM Partners
04/28/21 Wedbush
Pinterest price target lowered to $91 from $100 at Wedbush
SNAP Snap
$62.94 /

-0.66 (-1.04%)

06/02/21 Cowen
Poshmark pent up demand for apparel should bode well, says Cowen
05/21/21 Piper Sandler
Snap remains top pick in social advertising at Piper Sandler
05/10/21 Citi
Snap price target lowered to $42 from $47 at Citi
05/04/21 Citi
Snap price target raised to $47 from $40 at Citi
ARKF ARK Fintech Innovation ETF
$51.75 /

+0.02 (+0.04%)

ARKQ ARK Autonomous Technology & Robotics ETF
$82.24 /

+0.37 (+0.45%)

BABA Alibaba
$210.09 /

-0.95 (-0.45%)

05/17/21 Susquehanna
Alibaba opportunity ahead despite regulatory concerns, says Susquehanna
05/14/21 Truist
Alibaba price target lowered to $290 from $315 at Truist
05/14/21 Benchmark
Alibaba price target lowered to $285 from $310 at Benchmark
05/14/21 Baird
Alibaba price target lowered to $270 from $285 at Baird
BLDE Blade Air Mobility
$10.65 /

-0.6 (-5.33%)

06/03/21
Fly Intel: Top five analyst initiations
06/03/21 Citi
Blade Air Mobility initiated with a Buy at Citi
PINS Pinterest
$73.33 /

+2.18 (+3.06%)

SNAP Snap
$62.94 /

-0.66 (-1.04%)

BABA Alibaba
$210.09 /

-0.95 (-0.45%)

PINS Pinterest
$73.33 /

+2.18 (+3.06%)

SNAP Snap
$62.94 /

-0.66 (-1.04%)

BABA Alibaba
$210.09 /

-0.95 (-0.45%)

BLDE Blade Air Mobility
$10.65 /

-0.6 (-5.33%)

PINS Pinterest
$73.33 /

+2.18 (+3.06%)

SNAP Snap
$62.94 /

-0.66 (-1.04%)

BABA Alibaba
$210.09 /

-0.95 (-0.45%)

PINS Pinterest
$73.33 /

+2.18 (+3.06%)

SNAP Snap
$62.94 /

-0.66 (-1.04%)

ARKF ARK Fintech Innovation ETF
$51.75 /

+0.02 (+0.04%)

BABA Alibaba
$210.09 /

-0.95 (-0.45%)

BLDE Blade Air Mobility
$10.65 /

-0.6 (-5.33%)

ARKF ARK Fintech Innovation ETF
$51.75 /

+0.02 (+0.04%)

Recommendations
Score Media rallies with Credit Suisse positive ahead of sports betting vote » 10:43
06/22/21
06/22
10:43
06/22/21
10:43
SCR

Score Media

$24.90 /

+2.54 (+11.36%)

Today, bill C-218 will be…

Today, bill C-218 will be voted on in the Senate, which would legalize single-game sports betting in Canada, Credit Suisse analyst Benjamin Chaiken tells investors in a research note. Only multi-game parlays are permitted in the country currently, and online gambling is limited to state-run lottery organizations. Chaiken says he's been following the bill closely and thinks there is a "high likelihood of passage." Score Media and Gaming is positioned to be a market leader, he contends in a research note titled "The King in the North." The positive momentum in the legislation has led to a rally in the shares but there remains "sufficient room for upside," writes Chaiken. He believes that Score Media is positioned to be a market leader in Canada and estimates around 20% of Canadian sports fans are Score users. At $22.50 per share, there is essentially zero value for the U.S. and zero value for any provinces outside of Ontario, Chaiken adds. He keeps an Outperform rating on Score Media with a $50 price target. The stock in early trading is up 10% to $30.44.

ShowHide Related Items >><<
SCR Score Media
$24.90 /

+2.54 (+11.36%)

03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
  • 25
    Feb
SCR Score Media
$24.90 /

+2.54 (+11.36%)

SCR Score Media
$24.90 /

+2.54 (+11.36%)

SCR Score Media
$24.90 /

+2.54 (+11.36%)

Hot Stocks
Vivendi shareholders back spin-off of Universal Music Group » 10:40
06/22/21
06/22
10:40
06/22/21
10:40
VIVHY

Vivendi

$34.27 /

-0.12 (-0.35%)

, PSTH

Pershing Square Tontine Holdings

$22.94 /

+0.215 (+0.95%)

Vivendi (VIVHY) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIVHY Vivendi
$34.27 /

-0.12 (-0.35%)

PSTH Pershing Square Tontine Holdings
$22.94 /

+0.215 (+0.95%)

VIVHY Vivendi
$34.27 /

-0.12 (-0.35%)

06/01/21
Fly Intel: Top five analyst downgrades
06/01/21 Bernstein
Vivendi downgraded to Market Perform from Outperform at Bernstein
05/14/21 Credit Suisse
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse
04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
PSTH Pershing Square Tontine Holdings
$22.94 /

+0.215 (+0.95%)

  • 22
    Jul
VIVHY Vivendi
$34.27 /

-0.12 (-0.35%)

PSTH Pershing Square Tontine Holdings
$22.94 /

+0.215 (+0.95%)

VIVHY Vivendi
$34.27 /

-0.12 (-0.35%)

PSTH Pershing Square Tontine Holdings
$22.94 /

+0.215 (+0.95%)

PSTH Pershing Square Tontine Holdings
$22.94 /

+0.215 (+0.95%)

Hot Stocks
LexinFintech announces partnership with Huawei for Chinese consumer market » 10:39
06/22/21
06/22
10:39
06/22/21
10:39
LX

LexinFintech

$12.34 /

+0.215 (+1.77%)

LexinFintech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LX LexinFintech
$12.34 /

+0.215 (+1.77%)

LX LexinFintech
$12.34 /

+0.215 (+1.77%)

06/14/21 Morgan Stanley
LexinFintech upgraded to Overweight from Equal Weight at Morgan Stanley
06/14/21 Morgan Stanley
LexinFintech upgraded to Overweight from Equal Weight at Morgan Stanley
05/05/21 CICC
LexinFintech initiated with an Outperform at CICC
03/31/21 Morgan Stanley
Morgan Stanley says 360 Finance, Lufax should be least impacted by new PBOC rule
Hot Stocks
J&J confirms EC grants marketing authorization for expanded Darzalex use » 10:37
06/22/21
06/22
10:37
06/22/21
10:37
JNJ

Johnson & Johnson

$163.89 /

+0.06 (+0.04%)

The Janssen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.89 /

+0.06 (+0.04%)

JNJ Johnson & Johnson
$163.89 /

+0.06 (+0.04%)

07:37 Today JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
JNJ Johnson & Johnson
$163.89 /

+0.06 (+0.04%)

JNJ Johnson & Johnson
$163.89 /

+0.06 (+0.04%)

JNJ Johnson & Johnson
$163.89 /

+0.06 (+0.04%)

JNJ Johnson & Johnson
$163.89 /

+0.06 (+0.04%)

Conference/Events
Myovant Sciences participates in a conference call with JPMorgan » 10:35
06/22/21
06/22
10:35
06/22/21
10:35
MYOV

Myovant Sciences

$21.17 /

-0.2 (-0.94%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
$21.17 /

-0.2 (-0.94%)

MYOV Myovant Sciences
$21.17 /

-0.2 (-0.94%)

05/13/21 Citi
Myovant Sciences price target lowered to $24 from $30 at Citi
05/03/21 JPMorgan
Myovant Sciences price target lowered to $32 from $38 at JPMorgan
01/08/21 SVB Leerink
Myovant Sciences downgraded to Market Perform from Outperform at SVB Leerink
01/06/21 Goldman Sachs
Myovant Sciences downgraded to Neutral from Buy at Goldman Sachs
MYOV Myovant Sciences
$21.17 /

-0.2 (-0.94%)

MYOV Myovant Sciences
$21.17 /

-0.2 (-0.94%)

Options
Agenus put volume heavy and directionally bearish » 10:35
06/22/21
06/22
10:35
06/22/21
10:35
AGEN

Agenus

$5.34 /

+0.045 (+0.85%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGEN Agenus
$5.34 /

+0.045 (+0.85%)

AGEN Agenus
$5.34 /

+0.045 (+0.85%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley FBR
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
AGEN Agenus
$5.34 /

+0.045 (+0.85%)

AGEN Agenus
$5.34 /

+0.045 (+0.85%)

AGEN Agenus
$5.34 /

+0.045 (+0.85%)

General news
Treasury Action: the markets are little changed » 10:35
06/22/21
06/22
10:35
06/22/21
10:35
$ECON

Economic Data

/

+

Treasury Action: the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
FDA considers delaying decision on Incyte's retifanlimab » 10:34
06/22/21
06/22
10:34
06/22/21
10:34
INCY

Incyte

$85.26 /

+0.31 (+0.36%)

The FDA is considering…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$85.26 /

+0.31 (+0.36%)

INCY Incyte
$85.26 /

+0.31 (+0.36%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
INCY Incyte
$85.26 /

+0.31 (+0.36%)

INCY Incyte
$85.26 /

+0.31 (+0.36%)

INCY Incyte
$85.26 /

+0.31 (+0.36%)

INCY Incyte
$85.26 /

+0.31 (+0.36%)

Hot Stocks
Lincoln Financial appoints Jen Warne as EVP, CPO » 10:33
06/22/21
06/22
10:33
06/22/21
10:33
LNC

Lincoln National

$61.41 /

-0.39 (-0.63%)

Lincoln Financial Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LNC Lincoln National
$61.41 /

-0.39 (-0.63%)

LNC Lincoln National
$61.41 /

-0.39 (-0.63%)

05/18/21 B. Riley
Lincoln National price target raised to $72 from $56 at B. Riley
05/07/21 RBC Capital
Lincoln National price target raised to $69 from $59 at RBC Capital
04/20/21 UBS
Lincoln National initiated with a Neutral at UBS
04/12/21 Barclays
Lincoln National price target raised to $66 from $61 at Barclays
LNC Lincoln National
$61.41 /

-0.39 (-0.63%)

LNC Lincoln National
$61.41 /

-0.39 (-0.63%)

LNC Lincoln National
$61.41 /

-0.39 (-0.63%)

Hot Stocks
Blackstone hires Devin Glenn as Global Head of Diversity, Equity, Inclusion » 10:31
06/22/21
06/22
10:31
06/22/21
10:31
BX

Blackstone

$98.88 /

+0.56 (+0.57%)

Blackstone announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$98.88 /

+0.56 (+0.57%)

BX Blackstone
$98.88 /

+0.56 (+0.57%)

06/07/21 MoffettNathanson
QTS Realty buyout 'very appealing result,' says MoffettNathanson
04/27/21 Argus
Blackstone price target raised to $100 from $82 at Argus
04/23/21 Barclays
Blackstone price target raised to $95 from $85 at Barclays
04/23/21 Deutsche Bank
Blackstone price target raised to $76 from $66 at Deutsche Bank
BX Blackstone
$98.88 /

+0.56 (+0.57%)

BX Blackstone
$98.88 /

+0.56 (+0.57%)

BX Blackstone
$98.88 /

+0.56 (+0.57%)

BX Blackstone
$98.88 /

+0.56 (+0.57%)

Periodicals
Teva settles Mississippi generic pricing case for $925,0000, Bloomberg reports » 10:31
06/22/21
06/22
10:31
06/22/21
10:31
TEVA

Teva

$10.21 /

+0.1 (+0.99%)

Teva Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$10.21 /

+0.1 (+0.99%)

TEVA Teva
$10.21 /

+0.1 (+0.99%)

07:37 Today JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
TEVA Teva
$10.21 /

+0.1 (+0.99%)

TEVA Teva
$10.21 /

+0.1 (+0.99%)

TEVA Teva
$10.21 /

+0.1 (+0.99%)

TEVA Teva
$10.21 /

+0.1 (+0.99%)

Conference/Events
Wedbush Internet analyst to hold an analyst/industry conference call » 10:31
06/22/21
06/22
10:31
06/22/21
10:31
WIX

Wix.com

$292.78 /

+6.8 (+2.38%)

Internet Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WIX Wix.com
$292.78 /

+6.8 (+2.38%)

WIX Wix.com
$292.78 /

+6.8 (+2.38%)

06/14/21 RBC Capital
Wix.com price target raised to $315 from $300 at RBC Capital
06/14/21 RBC Capital
Squarespace initiated with a Sector Perform at RBC Capital
06/14/21 Goldman Sachs
Squarespace initiated with a Buy at Goldman Sachs
06/08/21 Atlantic Equities
Wix.com initiated with an Overweight at Atlantic Equities
WIX Wix.com
$292.78 /

+6.8 (+2.38%)

WIX Wix.com
$292.78 /

+6.8 (+2.38%)

General news
May existing home sales up 44.6% vs. last year  10:30
06/22/21
06/22
10:30
06/22/21
10:30
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

General news
May existing home sales down 0.9% vs. last month  10:30
06/22/21
06/22
10:30
06/22/21
10:30
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

Options
fuboTV call volume above normal and directionally bullish » 10:25
06/22/21
06/22
10:25
06/22/21
10:25
FUBO

FuboTV

$32.40 /

+0.8 (+2.53%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FUBO FuboTV
$32.40 /

+0.8 (+2.53%)

FUBO FuboTV
$32.40 /

+0.8 (+2.53%)

05/13/21 Barrington
FuboTV price target lowered to $30 from $40 at Barrington
05/12/21 Needham
FuboTV again exceeded commitments and guided metrics, says Needham
05/12/21 Evercore ISI
FuboTV's 'clean beat and raise' Q1 report a 'home run,' says Evercore ISI
04/05/21 Evercore ISI
FuboTV assumed with an Outperform at Evercore ISI
FUBO FuboTV
$32.40 /

+0.8 (+2.53%)

  • 30
    Dec
  • 08
    Oct
FUBO FuboTV
$32.40 /

+0.8 (+2.53%)

FUBO FuboTV
$32.40 /

+0.8 (+2.53%)

FUBO FuboTV
$32.40 /

+0.8 (+2.53%)

Conference/Events
Wedbush Internet analyst to hold an analyst/industry conference call » 10:25
06/22/21
06/22
10:25
06/22/21
10:25

Internet Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS leisure/lodging analyst to hold an analyst/industry conference call » 10:25
06/22/21
06/22
10:25
06/22/21
10:25

Gaming, Leisure &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Jefferies banking analysts to hold analyst/industry conference call » 10:25
06/22/21
06/22
10:25
06/22/21
10:25

Banking Analysts, along…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Southwest participates in a conference call with Benchmark » 10:25
06/22/21
06/22
10:25
06/22/21
10:25
LUV

Southwest

$55.77 /

-0.52 (-0.92%)

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LUV Southwest
$55.77 /

-0.52 (-0.92%)

LUV Southwest
$55.77 /

-0.52 (-0.92%)

06/09/21 MKM Partners
Southwest initiated with a Buy at MKM Partners
04/15/21 Barclays
Southwest price target raised to $64 from $51 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
LUV Southwest
$55.77 /

-0.52 (-0.92%)

LUV Southwest
$55.77 /

-0.52 (-0.92%)

LUV Southwest
$55.77 /

-0.52 (-0.92%)

LUV Southwest
$55.77 /

-0.52 (-0.92%)

Conference/Events
Euronet participates in a conference call with Northland » 10:25
06/22/21
06/22
10:25
06/22/21
10:25
EEFT

Euronet

$142.38 /

-1.22 (-0.85%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EEFT Euronet
$142.38 /

-1.22 (-0.85%)

EEFT Euronet
$142.38 /

-1.22 (-0.85%)

03/17/21 DA Davidson
Euronet price target raised to $180 from $166 at DA Davidson
03/17/21 Wells Fargo
Euronet price target raised to $180 from $165 at Wells Fargo
02/11/21 Needham
Euronet price target raised to $170 from $115 at Needham
02/11/21 Wells Fargo
Euronet price target raised to $165 from $110 at Wells Fargo
EEFT Euronet
$142.38 /

-1.22 (-0.85%)

On The Fly
Sanderson CEO may hold out for takeover price near $200 per share, analyst says » 10:24
06/22/21
06/22
10:24
06/22/21
10:24
SAFM

Sanderson Farms

$183.62 /

+12.84 (+7.52%)

, TSN

Tyson Foods

$74.18 /

+0.61 (+0.83%)

, PPC

Pilgrim's Pride

$22.06 /

+0.33 (+1.52%)

Shares of Sanderson Farms…

ShowHide Related Items >><<
SAFM Sanderson Farms
$183.62 /

+12.84 (+7.52%)

TSN Tyson Foods
$74.18 /

+0.61 (+0.83%)

PPC Pilgrim's Pride
$22.06 /

+0.33 (+1.52%)

SAFM Sanderson Farms
$183.62 /

+12.84 (+7.52%)

06:37 Today JPMorgan
Sanderson Farms price target raised to $198 from $175 at JPMorgan
06/02/21
Fly Intel: Top five analyst downgrades
06/02/21 Barclays
Sanderson Farms downgraded to Equal Weight from Overweight at Barclays
05/28/21 BMO Capital
Sanderson Farms price target raised to $195 from $180 at BMO Capital
TSN Tyson Foods
$74.18 /

+0.61 (+0.83%)

05/19/21
Fly Intel: Top five analyst upgrades
05/19/21 Argus
Tyson Foods upgraded to Buy from Hold at Argus
05/19/21 Argus
Tyson Foods upgraded to Buy from Hold at Argus
05/18/21 Credit Suisse
Sanderson Farms price target raised to $168 from $148 at Credit Suisse
PPC Pilgrim's Pride
$22.06 /

+0.33 (+1.52%)

06/03/21 Barclays
Pilgrim's Pride price target raised to $28 from $25 at Barclays
04/30/21 BMO Capital
Pilgrim's Pride price target raised to $28 from $21 at BMO Capital
04/09/21 Stephens
Tyson Foods price target raised to $90 from $80 at Stephens
02/08/21 Stephens
Pilgrim's Pride upgraded to Overweight on improving chicken view at Stephens
SAFM Sanderson Farms
$183.62 /

+12.84 (+7.52%)

TSN Tyson Foods
$74.18 /

+0.61 (+0.83%)

PPC Pilgrim's Pride
$22.06 /

+0.33 (+1.52%)

SAFM Sanderson Farms
$183.62 /

+12.84 (+7.52%)

TSN Tyson Foods
$74.18 /

+0.61 (+0.83%)

PPC Pilgrim's Pride
$22.06 /

+0.33 (+1.52%)

SAFM Sanderson Farms
$183.62 /

+12.84 (+7.52%)

TSN Tyson Foods
$74.18 /

+0.61 (+0.83%)

TSN Tyson Foods
$74.18 /

+0.61 (+0.83%)

General news
U.S. Richmond Fed's manufacturing index increased 4 points to 22 in June » 10:20
06/22/21
06/22
10:20
06/22/21
10:20
$ECON

Economic Data

/

+

U.S. Richmond Fed's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

Hot Stocks
Genmab says Janssen receives European marketing authorizations for DARZALEX » 10:17
06/22/21
06/22
10:17
06/22/21
10:17
GMAB

Genmab

$42.99 /

-0.06 (-0.14%)

, JNJ

Johnson & Johnson

$163.36 /

-0.47 (-0.29%)

Genmab (GMAB) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMAB Genmab
$42.99 /

-0.06 (-0.14%)

JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

GMAB Genmab
$42.99 /

-0.06 (-0.14%)

06/09/21 JPMorgan
Genmab price target raised to DKK 2,700 from DKK 2,500 at JPMorgan
06/07/21 UBS
Genmab price target raised to DKK 2,748 from DKK 2,500 at UBS
05/28/21 Deutsche Bank
Genmab price target raised to DKK 2,850 from DKK 2,750 at Deutsche Bank
05/17/21 JPMorgan
Genmab price target raised to DKK 2,500 from DKK 2,350 at JPMorgan
JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

07:37 Today JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

JNJ Johnson & Johnson
$163.36 /

-0.47 (-0.29%)

Technical Analysis
NASDAQ market internals summary » 10:17
06/22/21
06/22
10:17
06/22/21
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.